Advanced search
Publication Cover
Pharmaceutical Patent Analyst Volume 8, 2019 - Issue 4
Submit an article Journal homepage
8,303
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Current Patent and Clinical Status of Stimulator of Interferon Genes (STING) Agonists for Cancer Immunotherapy

Mickaël Marloye1 Microbiology Bioorganic & Macromolecular Chemistry Research Unit Faculté de Pharmacie Université libre de Bruxelles (ULB)Boulevard du TriompheBrussels1050Belgium
,
Sean E Lawler2 Harvey Cushing Neuro-Oncology Laboratories Department of Neurosurgery Brigham & Women’s Hospital Harvard Medical SchoolBostonMA02115USA
&
Gilles Berger1 Microbiology Bioorganic & Macromolecular Chemistry Research Unit Faculté de Pharmacie Université libre de Bruxelles (ULB)Boulevard du TriompheBrussels1050Belgium;2 Harvey Cushing Neuro-Oncology Laboratories Department of Neurosurgery Brigham & Women’s Hospital Harvard Medical SchoolBostonMA02115USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5418-9107
ORCID Icon
Pages 87-90 | Received 10 Jun 2019, Accepted 13 Jun 2019, Published online: 29 Jul 2019

References

  • Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
  • Leach DR , KrummelMF, AllisonJP. Enhancement of antitumor immunity by CTLA-4 Blockade. Science271(5256), 1734–1736 (1996).
  • Ishida Y , AgataY, ShibaharaK, HonjoT. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J.11(11), 3887–3895 (1992).
  • Dong H , ZhuG, TamadaK, ChenL. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med.5(12), 1365–1369 (1999).
  • Zhu H-F , LiY. Small-molecule targets in tumor immunotherapy. Nat. Prod. Bioprospect.8(4), 297–301 (2018).
  • Ribas A , WolchokJD. Cancer immunotherapy using checkpoint blockade. Science359(6382), 1350–1355 (2018).
  • Gajewski TF , SchreiberH, FuY-X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol.14(10), 1014–1022 (2013).
  • Sun L , WuJ, DuF, ChenX, ChenZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type i interferon pathway. Science339(6121), 786–791 (2013).
  • Corrales L , GajewskiTF. Molecular pathways: targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer. Clin. Cancer Res.21(21), 4774–4779 (2015).
  • Ohkuri T , KosakaA, IshibashiKet al. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. Cancer Immunol. Immunother.66(6), 705–716 (2017).
  • Deng L , LiangH, XuMet al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity41 (5), 543–852 (2014).
  • Corrales L , GlickmanLH, McWhirterSMet al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep.11(7), 1018–1030 (2015).
  • Li L , YinQ, KussPet al. Hydrolysis of 2’3’-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Nat. Chem. Biol.10(12), 1043–1048 (2014).
  • Aduro Biotech, Inc. : WO2013185052A1 (2013).
  • Aduro Biotech, Inc. : US9695212B2 (2017).
  • Aduro Biotech, Inc. : US20170218008A1 (2017).
  • Aduro Biotech, Inc. : US9724408B2 (2019).
  • University of Chicago and Aduro Biotech, Inc. : EP3071209A1 (2016).
  • University of Chicago and Aduro Biotech, Inc. : EP3071209A4 (2017).
  • Aduro Biotech, Inc. : AU2013358892B2 (2018).
  • Merck Sharp & Dohme Corp. : WO2017027645A1 (2017).
  • Merck Sharp & Dohme Corp. : CA2995365A (2017).
  • Glaxosmithkline Intellectual Property Development Ltd. : WO2015185565A1 (2015).
  • Bristol-Myers Squibb, Co. : WO2019079261A1 (2019).
  • Bibby MC , PhillipsRM, DoubleJA, PratesiG. Anti-tumour activity of flavone acetic acid (NSC 347512) in mice - influence of immune status. Br. J. Cancer63(1), 57–62 (1991).
  • Lara PN , DouillardJY, NakagawaKet al. Randomized Phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer. J. Clin. Oncol.29(22), 2965–2971 (2011).
  • Cancer Research Technology Ltd. : EP1759694A2 (2007).
  • Cancer Research Technology Ltd. : EP1423105B1 (2008).
  • Antisoma Plc. : WO2007023307A1 (2007).
  • Cancer Research Technology Ltd. : EP1423105B9 (2009).
  • Gao P , ZillingerT, WangWet al. Binding-pocket and lid-region substitutions render human STING sensitive to the species-specific drug DMXAA. Cell Rep.8(6), 1668–1676 (2014).
  • Hwang J , KangT, LeeJ, ChoiB-S, HanS. Design, synthesis, and biological evaluation of C7-functionalized DMXAA derivatives as potential human-STING agonists. Org. Biomol. Chem. (2018). https://pubs.rsc.org/en/content/articlelanding/2019/OB/C8OB01798K#!divAbstract
  • Ramanjulu JM , PesiridisGS, YangJet al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature564(7736), 439–443 (2018).
  • Glaxosmithkline Intellectual Property Development Ltd. WO2019069270A (2019).
  • Gao P , AscanoM, ZillingerTet al. Structure-function analysis of STING activation by c[G(2′,5′) pA(3′,5′)p] and targeting by antiviral DMXAA. Cell154(4), 748–762 (2013).
  • Shang G , ZhangC, ChenZJ, BaiXC, ZhangX. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP–AMP. Nature567(7748), 389–393 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.